Rady Elaraby focuses on genomic and epigenetic biomarker discovery and noncoding RNA regulation. Combines bioinformatics and liquid biopsy with lipid nanoparticle and nanocarrier delivery to translate RNA-based gene therapies in oncology, metabolic disease, and neurodegeneration.